STAT+: On Day 1 of JPM, no blockbuster headlines, but biotech newsmakers still move markets
This is the online version of The Readout, STAT’s flagship biotech newsletter. Sign up to get it in your inbox.
Hello from sunny San Francisco, where #BiotechVibeWatch2026 has begun. This is Allison DeAngelis, joined here by STAT’s Adam Feuerstein, Matthew Herper, and Elaine Chen.
There’s been endless chatter about the state of biotech lately. And if the cross-country flights from Logan Airport to San Francisco are any indicator, Boston and Kendall Square may still be in trouble. My flight out here was — unusually — not full, and I’ve heard other such examples. Am I scrutinizing the tea leaves too intensely, or is this another sign that Boston biotech is depressed? Email [email protected].
Allison DeAngelis, Adam Feuerstein, Matthew Herper, and Elaine Chen
Go to statnews